Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Cellyan Biotechnology Co., Ltd (HKPD) had Tangible Shareholders Equity of $4.89M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.73M |
|
$0.25M |
|
$0.35M |
|
$9.42M |
|
$2.92M |
|
$1.51M |
|
$1.51M |
|
$4.43M |
|
$4.99M |
|
|
Tangible Shareholders Equity |
$4.89M |
$4.99M |
|
-- |
|
| Cash Flow Statement Financials | |
$0.57M |
|
$-2.46M |
|
$2.00M |
|
$0.63M |
|
$0.75M |
|
$0.12M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|